David O' Neill
Direktor/Vorstandsmitglied bei Triphase Accelerator Corp.
Aktive Positionen von David O' Neill
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Fight Against Cancer Innovation Trust
 Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Private Equity Investor | - | - |
Triphase Accelerator Corp.
 Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Karriereverlauf von David O' Neill
Statistik
International
| Kanada | 3 |
Operativ
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Finance |
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- David O' Neill
- Erfahrung
